clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Lurie Children’s Developing Optical Genome Mapping Test for Brain Tumors
News & Features
Study Shines Light on Hereditary Back Issues
Informatics
Extrachromosomal DNA Spread Oncogenic Traits, Add Synthetic Lethal Targets
News & Features
Researchers Identify 36 Genes Linked to Cancer Drug Resistance
Molecular Dx
Three Distinct Types of Non-Alcoholic Fatty Liver Disease Discovered
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
The End of the Beginning for Cell and Gene Therapy, Part 2
Gene therapy (Therapeutics)
News & Features
The End of the Beginning for Cell and Gene Therapy, Part 2
Jonathan D. Grinstein, PhD
November 5, 2024
0
Multimedia
Behind the Breakthroughs: How to Turn $1,000,000 CAR Ts into “Real” Medicines
Jonathan D. Grinstein, PhD
October 30, 2024
0
Molecular Dx
Lexeo Therapeutics Scores Positive Early Data for APOE4-Alzheimer’s Gene Therapy
October 30, 2024
0
News & Features
Yes, We Can: BridgeBio Shares Positive Gene Therapy Data in Canavan Trial
Jonathan D. Grinstein, PhD
October 28, 2024
0
News & Features
First Patient Dosed with In Vivo Gene Therapy for CAR T
Jonathan D. Grinstein, PhD
October 23, 2024
0
News & Features
NEJM
Reports Detail Blood Cancers After Gene Therapy for Cerebral Adrenoleukodystrophy
October 16, 2024
0
News & Features
MeiraGTx’s Gene Therapy for Parkinson’s Scores in Midphase Trial
October 16, 2024
0
News & Features
The End of the Beginning for Cell and Gene Therapy
Jonathan D. Grinstein, PhD
October 8, 2024
0
News & Features
AviadoBio and Astellas Ink Potential $2.5B+ Deal for Frontotemporal Dementia Candidate
October 8, 2024
0
News & Features
In Conversation with Frank Gleeson
Helen Albert
October 7, 2024
0
1
2
3
...
17
Page 1 of 17
Related Content
Behind the Breakthroughs: How to Turn $1,000,000 CAR Ts into “Real” Medicines
Lexeo Therapeutics Scores Positive Early Data for APOE4-Alzheimer’s Gene Therapy
Gene Editing Insights Progress Delivery Inside Body
Yes, We Can: BridgeBio Shares Positive Gene Therapy Data in Canavan Trial
Inside Precision Medicine